InvestorsHub Logo
Followers 3
Posts 219
Boards Moderated 0
Alias Born 11/06/2016

Re: None

Tuesday, 12/06/2016 10:06:03 PM

Tuesday, December 06, 2016 10:06:03 PM

Post# of 3063
Elysium Raises $20M & Demonstrates Efficacy
This seems like a big deal to me. It's not just that Elysium is going to spend the $20M building a business that is centered around Chromodex ingredients (and potentially Chromodex purity control services), but that they would not have been able to raise so much money if their internal numbers weren't looking REALLY good in terms of sales growth.

My guess is that their investors viewed the primary business risks as (1) The pill does not in fact raise NAD+ levels, and (2) Someone else will beat them to the premium position as best supplement supplier. The test results solve the first problem, and the investment solves the second. They apparently are less concerned that NAD+ replenishment doesn't do what it obviously does.

http://www.businessinsider.com/elysium-health-raises-20-million-and-presents-clinical-data-2016-12
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXC News